Retrieve available abstracts of 78 articles: HTML format
Single Articles
June 2025
BERRY JD, de Lemos JA Biomarkers to Guide the Timing of Aortic Valve Replacement in Asymptomatic Aortic
Stenosis: Where Do We Stand After Early TAVR?
Circulation. 2025;151:1565-1567. PubMed
May 2025
PRABHU NK, Aykut B, Mensah-Mamfo M, Overbey DM, et al Partial Heart Transplantation: Early Experience With Pediatric Heart Valve
Replacements That Grow.
Circulation. 2025;151:1477-1490. PubMedAbstract available
DESAI MY, Wolski K, Owens A, Geske JB, et al Mavacamten in Patients With Hypertrophic Cardiomyopathy Referred for Septal
Reduction: Week 128 Results From VALOR-HCM.
Circulation. 2025;151:1378-1390. PubMedAbstract available
METRA M, Tomasoni D, Adamo M, Anker SD, et al Evidence Generation and Implementation of Transcatheter Interventions for
Atrioventricular Valvular Heart Disease in Heart Failure: Current Status and
Future Directions.
Circulation. 2025;151:1342-1363. PubMedAbstract available
April 2025
VEKSTEIN AM, Wegermann ZK, Manandhar P, Mack MJ, et al Outcomes of Transcatheter Aortic Valve Replacement in Low-Risk Patients in the
United States: A Report From the STS/ACC TVT Registry.
Circulation. 2025 Apr 3. doi: 10.1161/CIRCULATIONAHA.124.071838. PubMedAbstract available
March 2025
LINDMAN BR, Pibarot P, Schwartz A, Oldemeyer JB, et al Cardiac Biomarkers in Patients with Asymptomatic Severe Aortic Stenosis: Analysis
from the EARLY TAVR Trial.
Circulation. 2025 Mar 31. doi: 10.1161/CIRCULATIONAHA.125.074425. PubMedAbstract available
TANGUTURI VK, Abou-Karam R, Cheng F, Duan R, et al Electronic Provider Notification to Facilitate the Recognition and Management of
Severe Aortic Stenosis: a Randomized Clinical Trial.
Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074470. PubMedAbstract available
KAR S, Makkar RR, Whisenant BK, Hamid N, et al Two-year Outcomes of Transcatheter Edge-to-edge Repair for Severe Tricuspid
Regurgitation: The TRILUMINATE Pivotal Randomized Trial.
Circulation. 2025 Mar 30. doi: 10.1161/CIRCULATIONAHA.125.074536. PubMedAbstract available
MEISNER JK, Renberg A, Smith ED, Tsan YC, et al Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic
Cardiomyopathy.
Circulation. 2025;151:783-798. PubMedAbstract available
February 2025
ROSA M, Dupont A, Smadja DM, Soquet J, et al Aortic Valve Calcification Is Induced by the Loss of ALDH1A1 and Can Be Prevented
by Agonists of Retinoic Acid Receptor Alpha: Preclinical Evidence for Drug
Repositioning.
Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.124.071954. PubMedAbstract available
ZHANG B, Enriquez-Sarano M, Schaff HV, Michelena HI, et al Reactivation of Oxidized Soluble Guanylate Cyclase as a Novel Treatment Strategy
to Slow Progression of Calcific Aortic Valve Stenosis: Preclinical and Randomized
Clinical Trials to Assess Safety and Efficacy.
Circulation. 2025 Feb 24. doi: 10.1161/CIRCULATIONAHA.123.066523. PubMedAbstract available
January 2025
PARK SJ, Kang DH Response by Park and Kang to Letter Regarding Article, "Ertugliflozin for
Functional Mitral Regurgitation Associated With Heart Failure: EFFORT Trial".
Circulation. 2025;151:e28. PubMed
WANG J, Peng Y Letter by Wang and Peng Regarding Article, "Ertugliflozin for Functional Mitral
Regurgitation Associated With Heart Failure: EFFORT Trial".
Circulation. 2025;151:e27. PubMed
GUDMUNDSDOTTIR HL, Axelsson Raja A, Rossing K, Rasmusen H, et al Exercise Training in Patients With Hypertrophic Cardiomyopathy Without Left
Ventricular Outflow Tract Obstruction: A Randomized Clinical Trial.
Circulation. 2025;151:132-144. PubMedAbstract available
December 2024
TOMII D, Pilgrim T, Borger MA, De Backer O, et al Aortic Stenosis and Coronary Artery Disease: Decision-Making Between Surgical and
Transcatheter Management.
Circulation. 2024;150:2046-2069. PubMedAbstract available
November 2024
URENA M Transseptal Transcatheter Valve-in-Valve Mitral Valve Implantation: Ready for
Prime Time.
Circulation. 2024;150:1505-1507. PubMed
October 2024
RUDOLPH F, Geyer M, Baldus S, De Luca VM, et al Transcatheter Repair Versus Surgery for Atrial Versus Ventricular Functional
Mitral Regurgitation - a Post-hoc Analysis of the MATTERHORN Trial.
Circulation. 2024 Oct 30. doi: 10.1161/CIRCULATIONAHA.124.072648. PubMed
WEDIN JO, Naslund V, Rodin S, Simonson OE, et al Conduction Disturbances and Outcome After Surgical Aortic Valve Replacement in
Patients With Bicuspid and Tricuspid Aortic Stenosis.
Circulation. 2024 Oct 23. doi: 10.1161/CIRCULATIONAHA.124.070753. PubMedAbstract available
MAURIZI N, Antiochos P, Owens A, Lakdwala N, et al Long-Term Outcomes After Septal Reduction Therapies in Obstructive Hypertrophic
Cardiomyopathy: Insights From the SHARE Registry.
Circulation. 2024;150:1377-1390. PubMedAbstract available
BENKHOFF M, Barcik M, Mourikis P, Dahlmanns J, et al Targeting Sphingosine-1-Phosphate Signaling to Prevent the Progression of Aortic
Valve Disease.
Circulation. 2024 Oct 21. doi: 10.1161/CIRCULATIONAHA.123.067270. PubMedAbstract available
HOEDEMAKERS S, Cosyns B, Droogmans S, Verbrugge FH, et al Response by Hoedemakers et al to Letter Regarding Article, "mPAP/CO Slope and
Oxygen Uptake Add Prognostic Value in Aortic Stenosis".
Circulation. 2024;150:e278-e279. PubMed
JHA AK Letter by Jha Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic
Value in Aortic Stenosis".
Circulation. 2024;150:e276-e277. PubMed
September 2024
SANNINO A, Mahkmudova U Artificial Intelligence and Mitral Regurgitation: Friend or Foe?
Circulation. 2024;150:934-937. PubMed
Correction to: 2020 ACC/AHA Guideline for the Management of Patients With
Valvular Heart Disease: A Report of the American College of Cardiology/American
Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2024;150:e267. PubMed
CRIBIER A, Eltchaninoff H Transcatheter Aortic Valve Implantation: Two Decades of a Revolutionary and
Ongoing Odyssey.
Circulation. 2024;150:821-822. PubMed
RAMO J, Jurgens SJ, Kany S, Choi SH, et al Rare Genetic Variants in LDLR, APOB, and PCSK9 are Associated with Aortic
Stenosis.
Circulation. 2024 Sep 2. doi: 10.1161/CIRCULATIONAHA.124.070982. PubMedAbstract available
August 2024
SHRIDHAR P, Pal S, Clavere NG, Becker JR, et al Response by Shridhar et al to Letter Regarding Article, "MDM2 Regulation of HIF
Signaling Causes Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
Circulation. 2024;150:e201-e202. PubMed
DAVID TE Perspectives on Heart Valve Repair.
Circulation. 2024;150:661-662. PubMed
SUN Y, Ren J Letter by Sun and Ren Regarding Article, "MDM2 Regulation of HIF Signaling Causes
Microvascular Dysfunction in Hypertrophic Cardiomyopathy".
Circulation. 2024;150:e200. PubMed
VRUDHULA A, Duffy G, Vukadinovic M, Liang D, et al High-Throughput Deep Learning Detection of Mitral Regurgitation.
Circulation. 2024 Aug 12. doi: 10.1161/CIRCULATIONAHA.124.069047. PubMedAbstract available
GOEL K, Makkar R, Krishnaswamy A, Kapadia S, et al Contemporary Outcomes and Trends for the Transseptal Mitral Valve-in-Valve
Procedure Using Balloon Expandable Transcatheter Valves in the United States.
Circulation. 2024 Aug 5. doi: 10.1161/CIRCULATIONAHA.124.068847. PubMedAbstract available
July 2024
CARRIER L RNA Editing Holds Promise for Hypertrophic Cardiomyopathy Therapy.
Circulation. 2024;150:299-301. PubMed
YANG P, Lou Y, Geng Z, Guo Z, et al Allele-Specific Suppression of Variant MHC With High-Precision RNA Nuclease
CRISPR-Cas13d Prevents Hypertrophic Cardiomyopathy.
Circulation. 2024;150:283-298. PubMedAbstract available
June 2024
LONG A, Haggerty CM, Finer J, Hartzel D, et al Deep Learning for Echo Analysis, Tracking, and Evaluation of Mitral Regurgitation
(DELINEATE-MR).
Circulation. 2024 Jun 17. doi: 10.1161/CIRCULATIONAHA.124.068996. PubMedAbstract available
SMALL AM, Yutzey KE, Binstadt BA, Voigts Key K, et al Unraveling the Mechanisms of Valvular Heart Disease to Identify Medical Therapy
Targets: A Scientific Statement From the American Heart Association.
Circulation. 2024 Jun 17. doi: 10.1161/CIR.0000000000001254. PubMedAbstract available
QUAST C, Bonner F, Polzin A, Veulemans V, et al Aortic Valve Stenosis Causes Accumulation of Extracellular Hemoglobin and
Systemic Endothelial Dysfunction.
Circulation. 2024 Jun 5. doi: 10.1161/CIRCULATIONAHA.123.064747. PubMedAbstract available
MCGURK KA, Bilgehan N, Ware JS Pharmacogenetic Influences Over Mavacamten Pharmacokinetics: Considerations for
the Treatment of Individuals With Hypertrophic Cardiomyopathy.
Circulation. 2024;149:1786-1788. PubMed
OMMEN SR, Ho CY, Asif IM, Balaji S, et al 2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic
Cardiomyopathy: A Report of the American Heart Association/American College of
Cardiology Joint Committee on Clinical Practice Guidelines.
Circulation. 2024;149:e1239-e1311. PubMedAbstract available
May 2024
EVANGELISTA A, Galian-Gay L, Guala A, Teixido-Tura G, et al Atorvastatin Effect on Aortic Dilatation and Valvular Calcification Progression
in Bicuspid Aortic Valve (BICATOR): A Randomized Clinical Trial.
Circulation. 2024 May 28. doi: 10.1161/CIRCULATIONAHA.123.067537. PubMedAbstract available
KANG DH, Park SJ, Shin SH, Hwang IC, et al Ertugliflozin for Functional Mitral Regurgitation Associated With Heart Failure:
EFFORT Trial.
Circulation. 2024 May 1. doi: 10.1161/CIRCULATIONAHA.124.069144. PubMedAbstract available
April 2024
SHEN M, Wu JC Empowering Valvular Heart Disease Research With Stem Cell-Derived Valve Cells.
Circulation. 2024;149:1457-1460. PubMed
DAVIDSON LJ, Tang GHL, Ho EC, Fudim M, et al The Tricuspid Valve: A Review of Pathology, Imaging, and Current Treatment
Options: A Scientific Statement From the American Heart Association.
Circulation. 2024 Apr 25. doi: 10.1161/CIR.0000000000001232. PubMedAbstract available
LI B, Liu F, Chen X, Chen T, et al FARS2 Deficiency Causes Cardiomyopathy by Disrupting Mitochondrial Homeostasis
and the Mitochondrial Quality Control System.
Circulation. 2024;149:1268-1284. PubMedAbstract available
February 2024
HERRMANN HC, Desai ND Incidence, Implications, and Treatment of Patients With Severe Aortic Stenosis
and Small Aortic Annulus.
Circulation. 2024;149:656-657. PubMed
HOEDEMAKERS S, Pugliese NR, Stassen J, Vanoppen A, et al mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis.
Circulation. 2024 Feb 27. doi: 10.1161/CIRCULATIONAHA.123.067130. PubMedAbstract available
CRESCI S, Bach RG, Saberi S, Owens AT, et al Effect of Mavacamten in Women Compared With Men With Obstructive Hypertrophic
Cardiomyopathy: Insights From EXPLORER-HCM.
Circulation. 2024;149:498-509. PubMedAbstract available
January 2024
HAN D, Zhou T, Li L, Ma Y, et al AVCAPIR: A Novel Procalcific PIWI-Interacting RNA in Calcific Aortic Valve
Disease.
Circulation. 2024 Jan 23. doi: 10.1161/CIRCULATIONAHA.123.065213. PubMedAbstract available
TOPRICEANU CC, Pereira AC, Moon JC, Captur G, et al Meta-Analysis of Penetrance and Systematic Review on Transition to Disease in
Genetic Hypertrophic Cardiomyopathy.
Circulation. 2024;149:107-123. PubMedAbstract available
December 2023
SHRIDHAR P, Glennon MS, Pal S, Waldron CJ, et al MDM2 Regulation of HIF Signaling Causes Microvascular Dysfunction in Hypertrophic
Cardiomyopathy.
Circulation. 2023;148:1870-1886. PubMedAbstract available
November 2023
LIN Y, Yang Q, Lin X, Liu X, et al Extracellular Matrix Disorganization Caused by ADAMTS16 Deficiency Leads to
Bicuspid Aortic Valve With Raphe Formation.
Circulation. 2023 Nov 29. doi: 10.1161/CIRCULATIONAHA.123.065458. PubMedAbstract available
ROWIN EJ, Link MS, Maron MS, Maron BJ, et al Evolving Contemporary Management of Atrial Fibrillation in Hypertrophic
Cardiomyopathy.
Circulation. 2023;148:1797-1811. PubMedAbstract available
SEO K, Yamamoto Y, Kirillova A, Kawana M, et al Improved Cardiac Performance and Decreased Arrhythmia in Hypertrophic
Cardiomyopathy With Non-beta-Blocking R-Enantiomer Carvedilol.
Circulation. 2023;148:1691-1704. PubMedAbstract available
Correction to: 2020 ACC/AHA Guideline for the Management of Patients With
Valvular Heart Disease: A Report of the American College of Cardiology/American
Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2023;148:e185. PubMed
ROGERS MA, Bartoli-Leonard F, Zheng KH, Small AM, et al Major Facilitator Superfamily Domain Containing 5 Inhibition Reduces
Lipoprotein(a) Uptake and Calcification in Valvular Heart Disease.
Circulation. 2023 Nov 8. doi: 10.1161/CIRCULATIONAHA.123.066822. PubMedAbstract available
October 2023
RODES-CABAU J, Ribeiro H, Mohammadi S, Serra V, et al Transcatheter or Surgical Aortic Valve Replacement in Patients with Severe Aortic
Stenosis and Small Aortic Annulus: A Randomized Clinical Trial.
Circulation. 2023 Oct 26. doi: 10.1161/CIRCULATIONAHA.123.067326. PubMedAbstract available
KAPADIA SR, Krishnaswamy A, Whisenant B, Potluri S, et al Concomitant Left Atrial Appendage Occlusion and Transcatheter Aortic Valve
Replacement Among Patients with Atrial Fibrillation.
Circulation. 2023 Oct 24. doi: 10.1161/CIRCULATIONAHA.123.067312. PubMedAbstract available
DAHLE G, Al-Atassi T, Kaneko T The Future of Cardiac Surgical Training in the Age of Transcatheter Valvular
Interventions.
Circulation. 2023;148:1295-1297. PubMed
HARIRI E, Kassis N, Kapadia SR Letter by Hariri et al Regarding Article, "Vitamin K2 and D in Patients With
Aortic Valve Calcification: A Randomized Double-Blinded Clinical Trial".
Circulation. 2023;148:1267-1268. PubMed
HASIFIC S, Rasmussen LM, Dahl JS, Diederichsen ACP, et al Response by Hasific et al to Letter Regarding Article, "Vitamin K2 and D in
Patients With Aortic Valve Calcification: A Randomized Double-Blinded Clinical
Trial".
Circulation. 2023;148:1269-1270. PubMed
September 2023
JEX N, Greenwood JP, Cubbon RM, Rider OJ, et al Association Between Type 2 Diabetes and Changes in Myocardial Structure,
Contractile Function, Energetics, and Blood Flow Before and After Aortic Valve
Replacement in Patients With Severe Aortic Stenosis.
Circulation. 2023 Sep 25. doi: 10.1161/CIRCULATIONAHA.122.063444. PubMedAbstract available
FIGLIOZZI S, Georgiopoulos G, Masci PG Letter by Figliozzi et al Regarding Article, "The MIDA-Q Mortality Risk Score: A
Quantitative Prognostic Tool for the Mitral Valve Prolapse Spectrum".
Circulation. 2023;148:978-979. PubMed
ESSAYAGH B, Benfari G, Antoine C, Grigioni F, et al Response by Essayagh et al to Letter Regarding Article, "The MIDA-Q Mortality
Risk Score: A Quantitative Prognostic Tool for the Mitral Valve Prolapse
Spectrum".
Circulation. 2023;148:980-981. PubMed
AYERS MP, Kramer CM Imaging Myofibrillar Disarray and Microvascular Dysfunction in Hypertrophic
Cardiomyopathy: Novel Imaging Biomarkers for a New Era in Therapeutics.
Circulation. 2023;148:819-821. PubMed
JOY G, Kelly CI, Webber M, Pierce I, et al Microstructural and Microvascular Phenotype of Sarcomere Mutation Carriers and
Overt Hypertrophic Cardiomyopathy.
Circulation. 2023;148:808-818. PubMedAbstract available
August 2023
REINDL M, Lechner I, Holzknecht M, Tiller C, et al Cardiac Magnetic Resonance Imaging Versus Computed Tomography to Guide
Transcatheter Aortic Valve Replacement (TAVR-CMR): A Randomized, Open-Label,
Non-Inferiority Trial.
Circulation. 2023 Aug 27. doi: 10.1161/CIRCULATIONAHA.123.066498. PubMedAbstract available
PRAKASH SK, Michelena HI, Milewicz DM Bicuspid Aortic Valve and Thoracic Aortic Disease: Further Evidence of Clinically
Silent but Deadly Risk to Family Members of Affected Individuals.
Circulation. 2023;148:648-650. PubMed
Correction to: 2020 ACC/AHA Guideline for the Management of Patients With
Valvular Heart Disease: A Report of the American College of Cardiology/American
Heart Association Joint Committee on Clinical Practice Guidelines.
Circulation. 2023;148:e8. PubMed
ABOU ALAIWI S, Roston TM, Marstrand P, Claggett BL, et al Left Ventricular Systolic Dysfunction in Patients Diagnosed With Hypertrophic
Cardiomyopathy During Childhood: Insights From the SHaRe Registry.
Circulation. 2023;148:394-404. PubMedAbstract available
July 2023
ARMSTRONG DWJ, Riley LA, Su YR, Shah AS, et al Myocardial Neprilysin Is Increased in Hypertrophic Cardiomyopathy.
Circulation. 2023;148:167-169. PubMed
BLASER MC, Buffolo F, Halu A, Turner ME, et al Multiomics of Tissue Extracellular Vesicles Identifies Unique Modulators of
Atherosclerosis and Calcific Aortic Valve Stenosis.
Circulation. 2023 Jul 10. doi: 10.1161/CIRCULATIONAHA.122.063402. PubMedAbstract available
MONDA E, Limongelli G Letter by Monda and Limongelli Regarding Article, "The Prevalence and Association
of Exercise Test Abnormalities With Sudden Cardiac Death and Transplant-Free
Survival in Childhood Hypertrophic Cardiomyopathy".
Circulation. 2023;148:73. PubMed
June 2023
GLOTZBACH JP, Hanson HA, Tonna JE, Horns JJ, et al Familial Associations of Prevalence and Cause-Specific Mortality for Thoracic
Aortic Disease and Bicuspid Aortic Valve in a Large-Population Database.
Circulation. 2023 Jun 15. doi: 10.1161/CIRCULATIONAHA.122.060439. PubMedAbstract available
May 2023
GALPER BZ, Chinnakondepalli KM, Wang K, Magnuson EA, et al Economic Outcomes of Transcatheter Versus Surgical Aortic Valve Replacement in
Patients with Severe Aortic Stenosis and Low Surgical Risk: Results from the
PARTNER 3 Trial.
Circulation. 2023 May 8. doi: 10.1161/CIRCULATIONAHA.122.062481. PubMedAbstract available
April 2023
GOLLMANN-TEPEKOYLU C, Graber M, Hirsch J, Mair S, et al Toll-Like Receptor 3 Mediates Aortic Stenosis Through a Conserved Mechanism of
Calcification.
Circulation. 2023 Apr 4. doi: 10.1161/CIRCULATIONAHA.122.063481. PubMedAbstract available
March 2023
RAKOWSKI H, Bataiosu R Can Novel Myosin Inhibitors Defer Septal Reduction Therapy in HCM? At What Risk
and at What Cost?
Circulation. 2023;147:864-866. PubMed
DESAI MY, Owens A, Geske JB, Wolski K, et al Dose-Blinded Myosin Inhibition in Patients With Obstructive Hypertrophic
Cardiomyopathy Referred for Septal Reduction Therapy: Outcomes Through 32 Weeks.
Circulation. 2023;147:850-863. PubMedAbstract available
February 2023
TURER AT, Wang A Cardiac Myosin Inhibitors: Unlocking Potential to Improve Treatment in
Hypertrophic Cardiomyopathy.
Circulation. 2023;147:700-702. PubMed
CONWAY J, Min S, Villa C, Weintraub RG, et al The Prevalence and Association of Exercise Test Abnormalities With Sudden Cardiac
Death and Transplant-Free Survival in Childhood Hypertrophic Cardiomyopathy.
Circulation. 2023;147:718-727. PubMedAbstract available